Key Highlights
- Abnova's unique integration of IT-style management and industrial-scale antibody manufacturing sets them apart in the biotech industry.
- Their genome-wide approach to high throughput production of human proteins and antibodies ensures a vast and diverse range of antibody reagents.
- Abnova's multi-tiered sales network of over 49 distributors worldwide provides extensive market reach and accessibility.
- Their diversification into systems arena, including antibody pairs, ELISA kits, and instrumentation for rare cell isolation, showcases their commitment to innovation.
- Abnova's focus on in vitro diagnostics development, particularly non-invasive liquid biopsies, positions them as leaders in precision medicine.
About Abnova
Abnova is the first biotech company to successfully integrate IT-style management and industrial-scale antibody manufacturing. Their goal is to have at least one antibody for every human expressed gene in the human genome. They achieve this through a genome-wide approach to the high throughput production of human proteins and antibodies. Their products are marketed through a combination of e-commerce-based direct sales and a multi-tiered sales network of over 49 distributors worldwide.
Starting from 2009 to 2013, Abnova diversified into the systems arena, focusing on antibody pairs, ELISA kits, and instrumentation for rare cell isolation. In Phase III, they concentrated on in vitro diagnostics development, specifically non-invasive liquid biopsies of circulating tumor cells, ctDNA, and exosomes for precision medicine. Currently in Phase IV, they focus on drug development, specializing in immunotherapy.
Abnova welcomes researchers, biotech, and pharmaceutical companies to collaborate and succeed together. Their value-added business has set the path for future growth and provided opportunities for the company to contribute to the biotech industry at large.
Why Contact Abnova?
B2B professionals would contact Abnova for their extensive range of antibody reagents, innovative systems arena products, and expertise in precision medicine diagnostics. Their commitment to research and development in immunotherapy also makes them a valuable partner for drug development initiatives.
Who Should Contact Abnova for Business?
Sales teams specializing in biotech and pharmaceutical products, researchers seeking antibody reagents, and partners interested in precision medicine diagnostics should reach out to Abnova.
Categories
- antibody manufacturing
- biotech
- precision medicine
- ELISA kits
- rare cell isolation
- liquid biopsies
- circulating tumor cells
- ctDNA
- exosome diagnostics
- immunotherapy
More Biotechnology Companies
Frequently Asked Questions
- How many employees does Abnova have?
- Abnova has approximately 52 employees.
- Where is Abnova headquartered?
- Taipei, Taiwan, Province of China
- What industry is Abnova in?
- Abnova operates in Biotechnology, Pharmaceutical Research, Precision Medicine.
- When was Abnova founded?
- Abnova was founded in 2002.
- Is Abnova still active?
- Yes, Abnova was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Abnova?
- Research Abnova's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Abnova?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Abnova